A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
- PMID: 18187660
- DOI: 10.1182/blood-2007-11-121434
A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
Abstract
Post-polycythemia vera myelofibrosis (post-PV MF) is a late evolution of PV. In 647 patients with PV, we found that leukocytosis leukocyte count>(15x10(9)/L) at diagnosis is a risk factor for the evolution of post-PV MF. In a series of 68 patients who developed post-PV MF, median survival was 5.7 years. Hemoglobin level less than 100 g/L (10 g/dL) at diagnosis of post-PV MF was an independent risk factor for survival. The course of post-PV MF, however, is a dynamic process that implies a progressive worsening of clinical parameters. Using a multivariate Cox proportional hazard regression with time-dependent covariates, we found that a dynamic score based on hemoglobin level less than 100 g/L (10 g/dL), platelet count less than 100x10(9)/L, and leukocyte count more than 30x10(9)/L is useful to predict survival at any time from diagnosis of post-PV MF. The resulting hazard ratio of the score was 4.2 (95% CI: 2.4-7.7; P<.001), meaning a 4.2-fold worsening of survival for each risk factor acquired during follow up. In conclusion, leukocytosis at diagnosis of PV is a risk factor for evolution in post-PV MF. A dynamic score based on hemoglobin level, and platelet and leukocyte count predicts survival at any time from diagnosis of post-PV MF.
Similar articles
-
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎.Semin Hematol. 2018 Oct;55(4):248-255. doi: 10.1053/j.seminhematol.2018.05.013. Epub 2018 Jun 5. Semin Hematol. 2018. PMID: 30502854
-
Incidence and risk factors for myelofibrotic transformation among 272 Chinese patients with JAK2-mutated polycythemia vera.Am J Hematol. 2015 Dec;90(12):1116-21. doi: 10.1002/ajh.24191. Epub 2015 Nov 17. Am J Hematol. 2015. PMID: 26370613
-
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.Leukemia. 2017 Dec;31(12):2726-2731. doi: 10.1038/leu.2017.169. Epub 2017 May 31. Leukemia. 2017. PMID: 28561069
-
Polycythemia vera: from new, modified diagnostic criteria to new therapeutic approaches.Clin Adv Hematol Oncol. 2017 Sep;15(9):700-707. Clin Adv Hematol Oncol. 2017. PMID: 28949941 Review.
-
Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).Pathol Biol (Paris). 2007 Mar;55(2):92-104. doi: 10.1016/j.patbio.2006.06.002. Epub 2006 Aug 21. Pathol Biol (Paris). 2007. PMID: 16919893 Review.
Cited by
-
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.Blood Adv. 2018 Dec 26;2(24):3581-3589. doi: 10.1182/bloodadvances.2018024018. Blood Adv. 2018. PMID: 30563882 Free PMC article.
-
Polycythemia Vera.Curr Treat Options Oncol. 2018 Mar 7;19(2):12. doi: 10.1007/s11864-018-0529-x. Curr Treat Options Oncol. 2018. PMID: 29516275 Review.
-
Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.Haematologica. 2017 Sep;102(9):1511-1518. doi: 10.3324/haematol.2017.165795. Epub 2017 May 4. Haematologica. 2017. PMID: 28473622 Free PMC article.
-
Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.J Clin Med. 2024 Aug 22;13(16):4952. doi: 10.3390/jcm13164952. J Clin Med. 2024. PMID: 39201091 Free PMC article. Review.
-
Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia.Haematologica. 2012 Nov;97(11):1704-7. doi: 10.3324/haematol.2012.067348. Epub 2012 Jun 11. Haematologica. 2012. PMID: 22689671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources